StreetInsider.com News Articles

Amyris and Ingredion Wind Down RealSweet Joint Venture

Thu, 29 May 2025 16:30:00 -0400

Amyris takes full ownership of Brazilian precision fermentation plant and Ingredion obtains exclusive access to fermented Reb M technology

EMERYVILLE, Calif. and WESTCHESTER, Ill., May 29, 2025 /PRNewswire/ -- Amyris, Inc., a vertically integrated synthetic biology company and leading innovator in the field of industrial biotechnology, and Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to the food manufacturing industry, today announced an agreement to wind down their RealSweet joint venture. As part of the agreement, Amyris will assume 100% ownership of the

Amyris and Ingredion Wind Down RealSweet Joint Venture

Thu, 29 May 2025 16:30:00 -0400

Amyris takes full ownership of Brazilian precision fermentation plant and Ingredion obtains exclusive access to fermented Reb M technology

Amyris and Ingredion Wind Down RealSweet Joint Venture

Thu, 29 May 2025 16:30:00 -0400

Amyris takes full ownership of Brazilian precision fermentation plant and Ingredion obtains exclusive access to fermented Reb M technology

Amyris and Ingredion Wind Down RealSweet Joint Venture

Thu, 29 May 2025 16:30:00 -0400

Amyris takes full ownership of Brazilian precision fermentation plant and Ingredion obtains exclusive access to fermented Reb M technology

Amyris and Ingredion Wind Down RealSweet Joint Venture

Thu, 29 May 2025 16:30:00 -0400

Amyris takes full ownership of Brazilian precision fermentation plant and Ingredion obtains exclusive access to fermented Reb M technology

Amyris and Ingredion Wind Down RealSweet Joint Venture

Thu, 29 May 2025 16:30:00 -0400

Amyris takes full ownership of Brazilian precision fermentation plant and Ingredion obtains exclusive access to fermented Reb M technology

Amyris and Ingredion Wind Down RealSweet Joint Venture

Thu, 29 May 2025 16:30:00 -0400

Amyris takes full ownership of Brazilian precision fermentation plant and Ingredion obtains exclusive access to fermented Reb M technology

Amyris and Ingredion Wind Down RealSweet Joint Venture

Thu, 29 May 2025 16:30:00 -0400

Amyris takes full ownership of Brazilian precision fermentation plant and Ingredion obtains exclusive access to fermented Reb M technology

Amyris and Ingredion Wind Down RealSweet Joint Venture

Thu, 29 May 2025 16:30:00 -0400

Amyris takes full ownership of Brazilian precision fermentation plant and Ingredion obtains exclusive access to fermented Reb M technology

Amyris and Ingredion Wind Down RealSweet Joint Venture

Thu, 29 May 2025 16:30:00 -0400

Amyris takes full ownership of Brazilian precision fermentation plant and Ingredion obtains exclusive access to fermented Reb M technology

Amyris Takes Full Ownership of Brazilian Industrial Fermentation Plant and Invests in Completion of Fourth Precision Fermentation Line

Thu, 29 May 2025 16:30:00 -0400

EMERYVILLE, Calif., May 29, 2025 /PRNewswire/ -- Amyris, Inc., a vertically integrated synthetic biology company and leading innovator in the field of industrial biotechnology, today announced that it has acquired Ingredion's 31% stake in the RealSweet Joint Venture to take full ownership of the industrial precision fermentation plant in Barra Bonita, Brazil. This follows an agreement with Ingredion to wind down their RealSweet joint venture, whereby Ingredion will gain exclusive access to Amyris' technology to manufacture and commercialize fermented Reb M, with Amyris earning royalties on Ingredion's future sales of

Amyris Takes Full Ownership of Brazilian Industrial Fermentation Plant and Invests in Completion of Fourth Precision Fermentation Line

Thu, 29 May 2025 16:30:00 -0400

Amyris Takes Full Ownership of Brazilian Industrial Fermentation Plant and Invests in Completion of Fourth Precision Fermentation Line

Thu, 29 May 2025 16:30:00 -0400

Amyris Takes Full Ownership of Brazilian Industrial Fermentation Plant and Invests in Completion of Fourth Precision Fermentation Line

Thu, 29 May 2025 16:30:00 -0400

Amyris Takes Full Ownership of Brazilian Industrial Fermentation Plant and Invests in Completion of Fourth Precision Fermentation Line

Thu, 29 May 2025 16:30:00 -0400

Amyris Takes Full Ownership of Brazilian Industrial Fermentation Plant and Invests in Completion of Fourth Precision Fermentation Line

Thu, 29 May 2025 16:30:00 -0400

AVITA Medical Appoints Nicole Kelsey as Chief Legal and Compliance Officer, and Corporate Secretary

Mon, 01 Jul 2024 16:05:00 -0400

VALENCIA, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced the appointment of Nicole Linda Kelsey as Chief Legal and Compliance Officer, and Corporate Secretary, effective July 1, 2024.

Ms. Kelsey has more than two decades of executive legal experience with expertise in M&A, securities, and governance, along with a strong track record building and leading global regulatory and compliance programs. Previously, she served as Chief Legal Officer and Secretary for Amyris, Inc.

AVITA Medical Appoints Nicole Kelsey as Chief Legal and Compliance Officer, and Corporate Secretary

Mon, 01 Jul 2024 16:05:00 -0400

AVITA Medical Appoints Nicole Kelsey as Chief Legal and Compliance Officer, and Corporate Secretary

Mon, 01 Jul 2024 16:05:00 -0400

AVITA Medical Appoints Nicole Kelsey as Chief Legal and Compliance Officer, and Corporate Secretary

Mon, 01 Jul 2024 16:05:00 -0400

AVITA Medical Appoints Nicole Kelsey as Chief Legal and Compliance Officer, and Corporate Secretary

Mon, 01 Jul 2024 16:05:00 -0400

AVITA Medical Appoints Nicole Kelsey as Chief Legal and Compliance Officer, and Corporate Secretary

Mon, 01 Jul 2024 16:05:00 -0400

AVITA Medical Appoints Nicole Kelsey as Chief Legal and Compliance Officer, and Corporate Secretary

Mon, 01 Jul 2024 16:05:00 -0400

AVITA Medical Appoints Nicole Kelsey as Chief Legal and Compliance Officer, and Corporate Secretary

Mon, 01 Jul 2024 16:05:00 -0400

AVITA Medical Appoints Nicole Kelsey as Chief Legal and Compliance Officer, and Corporate Secretary

Mon, 01 Jul 2024 16:05:00 -0400